Search
Search
Four Eyes
06.20.24
In this episode, we dive deep into the revolutionary role of artificial intelligence in clinical trials and patient care with Dr. George Magrath, an esteemed ophthalmologist and the CEO of a cutting-edge pharmaceutical company specializing in ophthalmic drug development. Dr. Magrath shares his expertise, having trained in ocular oncology at the renowned Wills Eye Hospital in Philadelphia.
Dr. Magrath shares the innovative ways AI is being used in clinical trials, from patient selection to the development of new eye care medications. We also discuss how AI can accelerate the availability of effective ocular treatments and address wealth inequality in US healthcare. Lastly, we'll look ahead to the future prospects of AI in transforming ophthalmic pharmaceutical developments.
Tune in to discover how AI is reshaping the landscape of eye care and improving patient outcomes!
The Four Eyes Podcast is brought to you by YoungOD Connect
Learn more about Dr. Magrath
Learn more about companies using revolutionary AI technology in the medical space: Voxeleron, Verana Health, RETINA-AI
View full description +
Subscribe
07.21.25
93. Thriving, Not Just Surviving: A Mental Health Check-In for New Grads ft. Dr. Meenal AgarwalDr. Meenal Agarwal
06.02.25
91. Functional Medicine in Optometry with Dr. Christina GratkowskiDr. Christina Gratkowski
01.23.25
87. Cornea Chronicles Part 2: Managing Corneal Diseases ft. Dr. Sophia LeungDr. Sophia Leung
Show More
